Receptor-activity modifying protein 1 expression is increased in the striatum following repeated L-DOPA administration in a 6-hydroxydopamine lesioned rat model of Parkinson's disease. [electronic resource]
- Synapse (New York, N.Y.) Apr 2008
- 310-3 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0887-4476
10.1002/syn.20481 doi
Adrenergic Agents--toxicity Animals Corpus Striatum--drug effects Disease Models, Animal Dopamine Agents--pharmacology Dyskinesia, Drug-Induced--physiopathology Gene Expression In Situ Hybridization Intracellular Signaling Peptides and Proteins Levodopa--pharmacology Membrane Proteins--biosynthesis Motor Activity--drug effects Oxidopamine--toxicity Parkinsonian Disorders--drug therapy RNA, Messenger--analysis Rats Rats, Sprague-Dawley Receptor Activity-Modifying Protein 1 Receptor Activity-Modifying Proteins